• Je něco špatně v tomto záznamu ?

European principles of inhibitor management in patients with haemophilia

PLF. Giangrande, C. Hermans, B. O'Mahony, P. de Kleijn, M. Bedford, A. Batorova, J. Blatný, K. Jansone, European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD),

. 2018 ; 13 (1) : 66. [pub] 20180427

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028458

BACKGROUND: In spite of recent major advances in the understanding and treatment of inhibitor development in patients with haemophilia, multidisciplinary management of many of these patients remains suboptimal and highly heterogenous across Europe. METHODS: Following a series of multidisciplinary meetings and a review of the literature, the European haemophilia community of health professionals and patients jointly defined practical optimum standards for ensuring and harmonizing treatment and care for patients with an inhibitor. RESULTS: Ten complementary principles for the management of inhibitors in haemophilia have been developed, emphasizing the importance and benefits of a centralized, multidisciplinary, expert and holistic approach. CONCLUSIONS: This document will serve as a benchmark to improve the multidisciplinary and practical management of patients with inhibitor. Implementation and adherence to each of these principles should have a major positive impact on the management and outcomes of patients developing an inhibitor.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028458
003      
CZ-PrNML
005      
20190822110141.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13023-018-0800-z $2 doi
035    __
$a (PubMed)29703220
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Giangrande, P L F $u European Haemophilia Consortium, Rue de l'Industrie, B-1000, Brussels, Belgium. paul.giangrande@gtc.ox.ac.uk. University of Oxford, Oxford, UK. paul.giangrande@gtc.ox.ac.uk.
245    10
$a European principles of inhibitor management in patients with haemophilia / $c PLF. Giangrande, C. Hermans, B. O'Mahony, P. de Kleijn, M. Bedford, A. Batorova, J. Blatný, K. Jansone, European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD),
520    9_
$a BACKGROUND: In spite of recent major advances in the understanding and treatment of inhibitor development in patients with haemophilia, multidisciplinary management of many of these patients remains suboptimal and highly heterogenous across Europe. METHODS: Following a series of multidisciplinary meetings and a review of the literature, the European haemophilia community of health professionals and patients jointly defined practical optimum standards for ensuring and harmonizing treatment and care for patients with an inhibitor. RESULTS: Ten complementary principles for the management of inhibitors in haemophilia have been developed, emphasizing the importance and benefits of a centralized, multidisciplinary, expert and holistic approach. CONCLUSIONS: This document will serve as a benchmark to improve the multidisciplinary and practical management of patients with inhibitor. Implementation and adherence to each of these principles should have a major positive impact on the management and outcomes of patients developing an inhibitor.
650    _2
$a faktor IX $x metabolismus $7 D005164
650    _2
$a faktor VIII $x metabolismus $7 D005169
650    _2
$a hemofilie A $x metabolismus $7 D006467
650    _2
$a lidé $7 D006801
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Hermans, C $u Haemostasis and Thrombosis Unit, Division of Haematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
700    1_
$a O'Mahony, B $u European Haemophilia Consortium, Rue de l'Industrie, B-1000, Brussels, Belgium. Trinity College, Dublin, Ireland.
700    1_
$a de Kleijn, P $u Department of Rehabilitation, Nursing Science and Sports, University Medical Center Utrecht, Utrecht, The Netherlands.
700    1_
$a Bedford, M $u Canterbury Christ Church University, Kent, UK.
700    1_
$a Batorova, A $u National Hemophilia Center, Department of Hematology and Transfusion Medicine, School of Medicine of Comenius University and University Hospital, Bratislava, Slovakia.
700    1_
$a Blatný, J $u Children's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Jansone, K $u European Haemophilia Consortium, Rue de l'Industrie, B-1000, Brussels, Belgium.
710    2_
$a European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD)
773    0_
$w MED00165365 $t Orphanet journal of rare diseases $x 1750-1172 $g Roč. 13, č. 1 (2018), s. 66
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29703220 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822110419 $b ABA008
999    __
$a ok $b bmc $g 1433607 $s 1066918
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 13 $c 1 $d 66 $e 20180427 $i 1750-1172 $m Orphanet journal of rare diseases $n Orphanet J Rare Dis $x MED00165365
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace